Company Long-Term Debt: Lexeo Therapeutics (LXEO)

Brandmark of Lexeo Therapeutics, Inc. (LXEO)

Lexeo Therapeutics (LXEO) is developing gene therapy methods for the heart, optimizing international trials to protect profits and supply chains. This price chart shows Lexeo Therapeutics (LXEO) shares with long-term debt at 0.01, while the biotech's success depends on gene delivery safety and regulatory approvals. Looking ahead, the company plans to expand its pipeline of drugs for cardiopathies and Alzheimer's disease, safeguarding its unique vectors.

lexeotx.com (LXEO) Company Long-Term Liabilities: for the period 02/21/2024 - 10/29/2026

Summary analytical data breakdowns for Lexeo Therapeutics, Inc. (LXEO)

- market price and analyst price targets:
Stock Price Lexeo Therapeutics Inc.|LXEO - Price Target Chart
- company stock exchange capitalization indicators:
Market Value Lexeo Therapeutics|LXEO - Enterprise Value
- business book valuation details:
Net Asset Value per Share Lexeo Therapeutics|LXEO - Company Net Assets|Capitalization to Book Value Ratio lexeotx.com|LXEO - Company Total Assets
- business debt structure and liquidity details:
Debt to Capital Lexeo Therapeutics|LXEO - Long-Term Debt to Equity|Current Liabilities to Capital Lexeo Therapeutics Inc.|LXEO - Company Total Debt|Debt to Net Assets Ratio Lexeo Therapeutics|LXEO - Company Long-Term Liabilities|Amount of Current Liabilities Lexeo Therapeutics|Intermediate Coverage Ratio lexeotx.com
- earnings and market multiples details:
LXEO - Net Profit
Fundamental company valuation:Lexeo Therapeutics
Manufactured product of lexeotx.com

Long-term debt determines the level of a business's credit burden, impacting the final net income. Assessing a company's long-term borrowed capital allows for the identification of critical over-leverage points. This indicator aggregates all liabilities with a maturity of more than one year, measuring the financial stability of the structure. For Lexeo Therapeutics (LXEO), this metric is critical, as a high dependence on clinical trial outcomes makes debt servicing risky.

Competitor analysis for Lexeo Therapeutics

Company Long-Term Debts Tempus Labs TEM|QGEN - Company Long-Term Debt|IONS: Company Long-Term Debt|RGEN: Company Long-Term Debts|Long-Term Debt Avidity Corp (RNA)|Company Long-Term Liabilities CRSP|Company Long-Term Indebtedness WGS (genedx.com)|Company Long-Term Debts RARE|BEAM - Long-Term Debt|Company Long-Term Debt Sarepta Therapeutics Inc SRPT|Twist Bioscience Corp (TWST) - Long-Term Debt|TXG: Company Long-Term Liabilities|Company Long-Term Loans and Borrowings NTLA (intelliatx.com)|STOK (Stoke Therapeutics, Inc.) - Company Long-Term Liabilities|BLFS: Amount of Long-Term Liabilities|WVE (Wave Life Sciences Corp) - Company Long-Term Debts|MAZE: Company Long-Term Loans and Borrowings|Company Long-Term Debts SION|PRME - Long-Term Debt|Company Long-Term Debt Taysha Gene Therapies, Inc. TSHA|Company Long-Term Loans and Borrowings QURE|MeiraGTx PLC - Company Long-Term Debts|RGNX - Company Long-Term Debts|Solid Biosciences Inc. (SLDB) - Company Long-Term Debt|Long-Term Liabilities OCGN (ocugen.com)|PACB (PacBio) - Company Long-Term Debts|Long-Term Debt Benitec Biopharma Inc BNTC|Company Long-Term Liabilities DSGN (Design Pharma)|Company Long-Term Debts Rocket Corp (RCKT)|4D Molecular Therapeutics - Company Long-Term Liabilities|Amount of Long-Term Liabilities KRRO (Korro Bio Inc.)|Editas Medicine - Company Long-Term Debts|Long-Term Debt Volume Silence Therapeutics PLC SLN|PRQR: Company Long-Term Debts|Company Long-Term Liabilities Codexis|Company Long-Term Debt Sangamo Therapeutics|Nautilus Biotechnology Inc (NAUT) - Long-Term Debt Volume|Company Long-Term Debt Metagenomi (MGX)|Company Long-Term Debt DTIL (Precision BioSciences Inc.)|Generation Bio - Company Long-Term Liabilities|BOLD: Company Long-Term Indebtedness|Exicure Corp - Company Long-Term Debts|Long-Term Debt Imunon, Inc.|phiopharma.com (PHIO) - Company Long-Term Debt|Long-Term Debt Mustang Bio (MBIO)|RNAZ (TransCode Therapeutics Inc.) - Company Long-Term Debts|Company Long-Term Indebtedness BNGO (Bionano)|Company Long-Term Debt Applied DNA Sciences (APDN)|bluebirdbio.com - Company Long-Term Indebtedness|Company Long-Term Debts IPA (ImmunoPrecise Antibodies Ltd.)|Company Long-Term Debts Omega Therapeutics Inc OMGA|OMIC - Company Long-Term Debt|RGLS: Company Long-Term Debt|SYRS: Company Long-Term Debts|Long-Term Debt telesisbio.com (TBIO)|Company Long-Term Liabilities TCON|Company Long-Term Indebtedness UBX (Unity Biotechnology Inc.)